Videos

H. Steven Moffic, MD, explores the impact of moral injuries on psychiatrist burnout, emphasizing the need for healing and support in the profession.

Thomas Priolo, MD discusses strategies to manage back-to-school changes in child and adolescent psychiatric care.

Panelists discuss how successful implementation of xanomeline/trospium chloride requires understanding its unique mechanism of action, providing proper patient education about dosing requirements, starting with slow titration, and recognizing it as an early treatment option rather than a last resort.

"I found him on the porch that morning, sipping cold coffee, watching a crow..."

Experts discuss that Postpartum Support International is an invaluable resource offering education, training, and support to clinicians and families, while emphasizing the importance of strong local specialist networks for warm handoffs and streamlined referrals; combined with routine, repeated screening and proactive follow-up, these practices help reduce stigma and improve timely, compassionate care for perinatal mood disorders throughout pregnancy and postpartum.

Experts discuss that recent FDA-approved treatments like zuranolone offer rapid relief for postpartum depression, transforming care by enabling shorter, more effective pharmacologic courses; combined with tailored medication strategies, psychotherapy, and practical support around sleep and feeding, these advances promote comprehensive, individualized management that addresses both clinical symptoms and everyday challenges faced by new mothers

Experts discuss that limited access to qualified prescribers, particularly in underserved areas, remains a major barrier to timely pharmacologic treatment for perinatal mental health, underscoring the need for collaborative care models that combine thoughtful assessment, supportive interventions like sleep and therapy, and ongoing follow-up to ensure individualized, effective management.

Can we integrate politics, religion, and psychiatry for a better society?

Clinician's can use the new international guidelines for schizophrenia treatment to solidify treatment decisions and improve patient outcomes.

Panelists discuss how best practices involve starting with lower doses in older patients, considering long-term tolerability over acute symptom control, and potentially using xanomeline/trospium chloride as first-line treatment even for treatment-naive patients presenting with acute psychosis.

Panelists discuss how Lila’s late-onset schizophrenia at age 52 raises diagnostic concerns requiring thorough medical workup, and how her response to olanzapine with sedation and shakiness suggests the need for dose reduction or consideration of alternative treatments such as xanomeline/trospium chloride.

Daria Lewis, FNP, DNP, emphasizes the importance of patient connection and collaboration in managing bipolar disorder medications for improved daily functioning.

In his brand new video series, Joseph F. Goldberg, MD, sits down with Marlene Freeman, MD, to discuss the issue of SSRIs and pregnancy.

"Tonight their eyes meet with the spirit of sacred music, her body held between his legs like a cello, one hand stroking her neck, his arm curled around her waist."

Experts discuss that after a positive screen for perinatal mood or anxiety disorders, timely and compassionate intervention—through trusted resources like Postpartum Support International, thoughtful medication and therapy options, and patient-centered education that addresses stigma and supports shared decision-making—is key to achieving meaningful recovery and improved parent-infant outcomes.

Experts discuss that reducing stigma, normalizing mental health conversations from the first prenatal visit, expanding access through integrated and virtual care, and addressing systemic barriers through education, collaboration, and policy reform are all critical strategies for improving the detection and treatment of perinatal mood and anxiety disorders.

We have major mental health risks in our country’s divisiveness and international wars.

Panelists discuss how xanomeline/trospium chloride should be positioned as a first-line treatment option rather than waiting for treatment failures, given its superior effect size, comprehensive symptom coverage, and favorable tolerability profile compared with that of traditional antipsychotics.

Panelists discuss how switching patients to xanomeline/trospium chloride requires different cross-titration strategies depending on whether patients are on “done” medications versus “pines” medications, with special attention to anticholinergic effects when transitioning from sedating antipsychotics.

"Even the smallest insects are singing, vibrating their entire bodies, tiny violins of longing and desire. We were made for song."

Experts discuss that while standardized screening tools are important for detecting perinatal mood and anxiety disorders, true identification often relies on provider intuition, meaningful dialogue, and cross-specialty collaboration—especially in pediatric settings—to ensure timely support for both parent and child.

Experts discuss that effective management of perinatal mood and anxiety disorders in primary care and obstetrics requires routine screening, clear referral pathways, provider education, and collaborative care to ensure timely diagnosis and treatment.

H. Steven Moffic, MD, suggests its time to reassess our ethical priorities.

Explore how innovation anxiety affects personal and professional lives, and discover strategies to embrace change and reduce stress effectively.

Explore the healing power of poetry as psychiatrists discuss trauma, transformation, and connection in their latest insightful conversation.

Panelists discuss how real-world experience with xanomeline/trospium chloride shows efficacy across all 3 symptom domains with manageable gastrointestinal adverse effects that typically resolve within 2 weeks, requiring slow titration and patient education about empty stomach dosing.

Panelists discuss how xanomeline/trospium chloride represents a first-in-class medication with a novel muscarinic mechanism that addresses positive, negative, and cognitive symptoms while avoiding typical antipsychotic adverse effects such as movement disorders and prolactin elevation.

Tom Hildebrandt, PsyD, explores how sex hormones influence eating disorders, revealing critical insights into binge eating and bulimia nervosa.

"My sons, daughters, young lovers and friends. I don’t know them."